These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 7051310)
21. Normal physiology of copper metabolism. Winge DR Semin Liver Dis; 1984 Aug; 4(3):239-51. PubMed ID: 6385271 [No Abstract] [Full Text] [Related]
22. Liver copper in health and disease. Epstein O Postgrad Med J; 1983; 59 Suppl 4():88-94. PubMed ID: 6647221 [No Abstract] [Full Text] [Related]
23. Correlation between disappearance of the intrahepatic bile ducts and histologic changes in the liver in primary biliary cirrhosis. Nakanuma Y; Miyamura H; Ohta G; Kobayashi K; Kato Y; Hattori N Am J Gastroenterol; 1981 Dec; 76(6):506-10. PubMed ID: 7331981 [TBL] [Abstract][Full Text] [Related]
24. A controlled trial of D-penicillamine therapy in primary biliary cirrhosis. Jain S; Scheuer PJ; Samourian S; McGee JO Lancet; 1977 Apr; 1(8016):831-4. PubMed ID: 67338 [TBL] [Abstract][Full Text] [Related]
25. The syndrome of primary biliary cirrhosis. Dickson ER J Rheumatol Suppl; 1981; 7():121-3. PubMed ID: 6939874 [TBL] [Abstract][Full Text] [Related]
26. Primary biliary cirrhosis: a challenging disease for hepatologists and immunologists. Jones EA Semin Liver Dis; 1981 Nov; 1(4):267-72. PubMed ID: 7051307 [No Abstract] [Full Text] [Related]
34. Triethylene tetramine dihydrochloride toxicity in primary biliary cirrhosis. Epstein O; Sherlock S Gastroenterology; 1980 Jun; 78(6):1442-5. PubMed ID: 6445305 [TBL] [Abstract][Full Text] [Related]
35. A prospective clinical trial of D-penicillamine in the treatment of primary biliary cirrhosis. Bodenheimer HC; Schaffner F; Sternlieb I; Klion FM; Vernace S; Pezzullo J Hepatology; 1985; 5(6):1139-42. PubMed ID: 3905561 [TBL] [Abstract][Full Text] [Related]
36. Orcein positive hepatocellular material in long-standing biliary diseases. I. Histochemical characteristics. Sipponen P Scand J Gastroenterol; 1976; 11(6):545-52. PubMed ID: 62382 [TBL] [Abstract][Full Text] [Related]
37. [The bile acids in primary biliary cirrhosis. Comparison with other hepatic diseases]. Rautureau M; Lemonnier F; Chevrel B Rev Int Hepatol; 1966; 16(2):193-205. PubMed ID: 5947842 [No Abstract] [Full Text] [Related]
39. [Therapy of liver cirrhosis]. Paumgartner G Z Gastroenterol Verh; 1983 Apr; 18():63-9. PubMed ID: 6192610 [No Abstract] [Full Text] [Related]
40. Effect of long-term treatment with ursodiol on clinical and biochemical features and biliary bile acid metabolism in patients with primary biliary cirrhosis. Batta AK; Salen G; Mirchandani R; Tint GS; Shefer S; Batta M; Abroon J; O'Brien CB; Senior JR Am J Gastroenterol; 1993 May; 88(5):691-700. PubMed ID: 8480734 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]